A close-up image of someone donating blood. He is squeezing a stress ball during a medical process and showing that giving blood voluntarily can be done safely.
When a patient receives a blood transfusion in a hospital anywhere in India, they are placing a fundamental trust in a process they cannot see and rarely think about.
The trust is this: that the blood entering their bloodstream has been tested, verified, and declared safe — free of the viruses and parasites that blood can carry and transmit, and compatible with their own blood type.
That trust is not misplaced. India's blood safety system, while imperfect, is built on multiple layers of testing that have significantly reduced transfusion-transmitted infections over the past three decades. And a newer technology — Nucleic Acid Testing (NAT) — is making it safer still.
Under the Drugs and Cosmetics Act of India, every unit of donated blood must be tested before release for five transfusion-transmitted infections (TTIs):
Any blood unit that tests positive for any of these infections is immediately discarded. The donor is confidentially notified and referred for appropriate medical follow-up.
These mandatory five TTI tests apply to every blood bank in India — government, private, and trust-run — without exception.
The standard method of TTI testing in Indian blood banks is serology — detecting infection by identifying the body's immune response (antibodies and antigens) to specific pathogens.
For HIV, this involves detecting anti-HIV antibodies or the p24 antigen. For Hepatitis B, the HBsAg antigen is the primary marker. For Hepatitis C, anti-HCV antibodies are detected.
Serology is well-established, cost-effective, and highly reliable — but it has one critical limitation: the window period.
When a person is first infected with HIV or Hepatitis B or C, their immune system takes time to generate detectable levels of antibodies and antigens. During this window — which can last from a few days to several weeks depending on the virus — the blood contains the pathogen but standard serology tests return negative results.
A blood unit donated during this window period could pass all standard tests and still transmit infection to a recipient.
This is the gap that Nucleic Acid Testing is designed to close.
NAT is a molecular technique that directly detects the genetic material (DNA or RNA) of a virus — rather than the body's immune response to it. Because it detects the virus itself, not antibodies that develop weeks later, NAT can identify infections in the earliest stages of viremia — the period when the virus is present in the blood but before the immune system has responded.
The practical impact:
A 15-year retrospective study from Max Healthcare, New Delhi, covering 211,555 blood donations from 2010–2024, found that NAT detected 205 additional TTI cases that had been missed by standard serology — cases that would have reached patients undetected without NAT screening. The HBV NAT yield rate was 1:1262 — meaning roughly one in 1,262 seronegative donations contained active HBV infection detectable only by NAT.
Scaled to India's 14.6 million annual donations, this yield rate suggests that tens of thousands of potentially infectious units could be entering the blood supply annually from blood banks that rely on serology alone.
NAT is not yet universally implemented across India's blood banking system. As of recent data:
The Government of India's 2026 blood transfusion plan specifically targets the expansion of NAT as a priority. Madhya Pradesh has piloted a centralised "hub-and-spoke" NAT model — where blood samples from multiple satellite blood banks in districts are transported to central hubs in Indore and Bhopal for NAT testing, making it affordable without requiring expensive equipment at each individual blood bank.
The Madhya Pradesh model represents a practical approach to scaling NAT in resource-limited settings — and is being studied as a template for national implementation.
Beyond technology, the safety of India's blood supply is significantly influenced by who donates.
A groundbreaking finding from the Max Healthcare 15-year NAT study: of the 3,333 total seropositive donations detected over the study period, 98.68% came from replacement donors — not voluntary donors. The voluntary donor pool was significantly safer.
This is not a coincidence. Replacement donors — people donating under social pressure in hospital corridors — have higher rates of concealing risk factors. They may have a history of multiple sexual partners, intravenous drug use, or recent high-risk behaviour that they do not disclose because the stakes of being turned away feel unbearable with their family member waiting for blood.
Voluntary donors — who donate regularly, without external pressure, and are motivated by altruism rather than obligation — are significantly more likely to accurately report their health history, self-exclude when they have risk factors, and represent a lower-risk population overall.
Every replacement donor replaced by a voluntary donor improves blood safety. This is one of the strongest medical arguments for the national goal of 100% voluntary blood donation.
In addition to infectious disease testing, every donated blood unit is tested for its ABO blood group and Rh factor — and this information is confirmed again when the blood is matched to a specific patient.
Before any blood is transfused, a crossmatch is performed — the donor's blood is mixed with the recipient's serum to check for compatibility reactions. Only blood that passes crossmatching is released for transfusion.
This dual verification — initial typing of the donated blood plus patient-specific crossmatching — is the safety net that prevents the haemolytic transfusion reactions that occurred before modern blood typing was understood.
Blood donation includes a health benefit that many donors underestimate: your blood is tested before use.
If your donated blood tests positive for any of the five mandatory TTIs, the blood bank is required to notify you confidentially and refer you for medical evaluation and counselling. For many donors — particularly those who have never been tested for HIV or Hepatitis B and C — this is the first time they receive this information.
While the discovery of a positive test is distressing, early diagnosis enables earlier treatment and prevents further transmission. Blood donation inadvertently functions as a public health screening tool for some of India's most significant infectious diseases.
Donating blood at a licensed, accredited blood bank in India is safe for you — equipment is single-use and sterile — and the blood you donate will be thoroughly tested before reaching any patient.
The safety improvements over the past 30 years — mandatory five-TTI testing, the shift toward voluntary donation, the expansion of NAT — represent real, documented progress. The goal of making every unit of Indian blood the safest it can possibly be is ongoing, and every voluntary donor who replaces a replacement donor moves the system in the right direction.
Register on TheBloodApp today. Donate at a licensed blood bank. Trust the system that is working to protect both you and the patients you help. To find donation camps and blood banks near you across India, call the number listed in the app.
Sources: PMC — NAT Blood Banks India 15-Year Study Max Healthcare 2025 | PMC — Automated NAT Blood Banks India | PMC — Blood Safety Madhya Pradesh Centralised NAT Model | Medindia — India's 2026 Blood Plan | NBTC India — TTI Testing Guidelines | WHO India Blood Safety 2024 | Cureus — Added Value NAT Blood Banks India
Stay informed, stay inspired — your go-to source for everything about blood donation and impact.
Every unit of blood donated in India is tested for HIV, Hepatitis B, Hepatitis C, Syphilis, and Malaria. Here's how blood safety testing works — and how NAT is making the system even safer.
Only 6% of India's blood donors are women — despite women accounting for massive blood demand in obstetrics. Here's why the gender gap exists and what can be done about it.
Every monsoon, dengue sweeps India and platelet counts plummet in thousands of patients. Here's why July to October is the most critical period for platelet donation across India.
Be a part of the change — donate safely, stay connected, and help someone in need. Download the app today.
Available on
